SEC Form D · filed January 8, 2021
Hoth Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Vadim Mats · New York, NYDirectorRobb Knie · New York, NYExec · DirectorDavid Sarnoff · New York, NYDirectorDavid Briones · New York, NYExecWayne Linsley · New York, NYDirectorGraig Springer · New York, NYDirectorRobert Grant · Denver, COExec · DirectorTroy Dayton · Boulder, CODirectorWendye J. Robbins · South San Francisco, CADirectorTimothy Bovard · New Orleans, LAExecStefanie Johns · New York, NYExecChristopher D. Reid · USAQUEN, BOGATA, MauritiusExec · DirectorFelipe D. De La Vega Vargara · USAQUEN, BOGATA, MauritiusDirectorIan M. Lawrence · Toronto, Ontario, CanadaDirectorSedef M. Koktenturk · LUXEMBOURG, LuxembourgExecStefanie Johns · New York, NYExecWayne Linsley · New York, NYDirectorGraig Springer · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗